These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19077695)
1. Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Deelman L; Sharma K Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):85-90. PubMed ID: 19077695 [TBL] [Abstract][Full Text] [Related]
2. Activation of a local renin angiotensin system in podocytes by glucose. Durvasula RV; Shankland SJ Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149 [TBL] [Abstract][Full Text] [Related]
3. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Li J; Bertram JF Nephrology (Carlton); 2010 Aug; 15(5):507-12. PubMed ID: 20649869 [TBL] [Abstract][Full Text] [Related]
4. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. López-Hernández FJ; López-Novoa JM Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921 [TBL] [Abstract][Full Text] [Related]
5. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease]. Shao DC; Lu LM Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414 [TBL] [Abstract][Full Text] [Related]
7. Research into the glomerular podocyte--is it relevant to diabetic nephropathy? White KE Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474 [TBL] [Abstract][Full Text] [Related]
8. Progression of chronic kidney disease: can it be prevented or arrested? Jaber BL; Madias NE Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772 [TBL] [Abstract][Full Text] [Related]
9. Relaxin and the progression of kidney disease. Samuel CS; Hewitson TD Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683 [TBL] [Abstract][Full Text] [Related]
11. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Reddy GR; Kotlyarevska K; Ransom RF; Menon RK Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667 [TBL] [Abstract][Full Text] [Related]
13. [Mechanisms in remodeling of the kidney]. Nangaku M; Miyata T Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic targets for treating fibrotic kidney diseases. Lee SY; Kim SI; Choi ME Transl Res; 2015 Apr; 165(4):512-30. PubMed ID: 25176603 [TBL] [Abstract][Full Text] [Related]
16. [Reversal of renal fibrosis: lessons from experimental models]. Dussaule JC; Chatziantoniou C Bull Acad Natl Med; 2008 May; 192(5):987-1000; discussion 1000-1. PubMed ID: 19238788 [TBL] [Abstract][Full Text] [Related]
17. Cytokines and renin-angiotensin system signaling in hepatic fibrosis. Moreno M; Bataller R Clin Liver Dis; 2008 Nov; 12(4):825-52, ix. PubMed ID: 18984469 [TBL] [Abstract][Full Text] [Related]